Push Admin

FDA: AstraZeneca, with data complete, cancels clinical-trial application in PH

Article (news)

Raphael Bosano, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/11/19/health-coronavirus-argentina-astrazeneca_1.jpg"/><figcaption>Vials with a sticker reading, &quot;COVID-19 / Coronavirus vaccine / Injection only&quot; and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken Oct. 31, 2020. <em>Dado Ruvic, Reuters/file</em></figcaption></figure></div><p>MANILA — UK-based pharmaceutical company AstraZeneca has withdrawn its application to conduct clinical trials in the country, Food and Drug Administration Director-General Dr. Eric Domingo confirmed on Friday. </p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/11/24/20/easy-cheap-to-produce-astrazenecas-covid-vaccine-appears-effective">Easy, cheap to produce AstraZeneca’s COVID vaccine appears effective</a></li></ul><p>In a phone interview, Domingo said AstraZeneca has deemed its data complete to support its efficacy.</p><p>“Nag-notify sila sa FDA na winithdraw nila yung kanilang application dahil ang kanilang binigay na dahilan ay kumpleto na ang kanilang data para maipakita ang efficacy ng kanilang vaccine and to support yung kanilang magiging application for EUA,” he said. </p><p>This means that the initially planned clinical trial following a vaccine expert panel and ethics board-approved protocol will most likely no longer push through. The FDA, however, is still open to accepting applications should AstraZeneca still decide to conduct another trial. </p><p>But should the drugmaker decide to conduct another trial using a different protocol, they would have to go back to the first step of the regulatory process. </p><div><strong>RELATED VIDEO: </strong></div><figure class="op-interactive"><iframe height="315" src="https://www.youtube.com/embed/9UM37lWno4s?enablejsapi=1" width="560"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div><p>“Kung magkaroon ng bagong protocol. For example, magiging iba na yung design ng kanilang study, halimbawa babaguhin yung dosage or yung study population ay iba na sa original protocol na sinumbit nila then they would have to go to step 1 again,” Domingo said. </p><p>The withdrawal of AstraZeneca has left the FDA with 2 applications. The agency is also expecting another application to be filed by Johnson and Johnson’s Janssen.</p><p>“Ang naka-lodge sa atin na applications yung sa Sinovac at Clover. Hinihintay natin magsubmit yung Janssen kasi mukhang nakalusot na rin sila sa vaccine expert panel pero hindi pa sila officially nagsusubmit ng application sa FDA,” he said. </p><p>Domingo said even if AstraZeneca hasn’t conducted a clinical trial in the country, it can still file an application. </p><p>“Kailangan lang maipakita nila kung meron silang subset ng pasyente na similar sa atin na mga Asians or racially very similar to Filipinos. Kung mapakita na maganda rin ang safety at efficacy pwede naman mag apply sa atin pa rin,” Domingo said.</p>

<p>UK-based pharmaceutical company AstraZeneca has withdrawn its application to conduct clinical trials in the country. </p>

UK-based pharmaceutical company AstraZeneca has withdrawn its application to conduct clinical trials in the country.

FDA: AstraZeneca, with data complete, cancels clinical-trial application in PH

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

FDA: AstraZeneca, with data complete, cancels clinical-trial application in PH

Raphael Bosano,

ABS-CBN News

Published Dec 11, 2020 06:21 PM PHT

Read More:

COVID-19 update

coronavirus

coronavirus vaccine update

COVID-19 vaccine update

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.